ExThera Medical is a privately held Delaware C corporation.
The company's focus is on the introduction of innovative device-based clinical treatments for both drug-resistant and drug-susceptible bloodstream infections, as well as prophylactic methods to safeguard banked human blood.
Institutions and accredited investors with an interest in investing in ExThera Medical are encouraged to contact the following for information on current investment programs:
George Pitarra, Jr. | EXECUTIVE VICE PRESIDENT & CHIEF FINANCIAL OFFICER
ExThera Medical Corporation
E Mail: George Pitarra